S
44.78
-0.16 (-0.36%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Soleno Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
2.1
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 2.13 |
|
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 2.93% |
| 机构持股比例 | 113.72% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 123.00 (Cantor Fitzgerald, 174.68%) | 购买 |
| 中 | 103.50 (131.13%) | |
| 低 | 81.00 (Guggenheim, 80.88%) | 购买 |
| 平均值 | 103.17 (130.39%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 69.69 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 31 Mar 2025 | 100.00 (123.31%) | 购买 | 71.99 |
| 03 Mar 2025 | 70.00 (56.32%) | 购买 | 45.80 | |
| Guggenheim | 28 Mar 2025 | 81.00 (80.88%) | 购买 | 71.99 |
| Stifel | 28 Mar 2025 | 108.00 (141.18%) | 购买 | 71.99 |
| 05 Mar 2025 | 74.00 (65.25%) | 购买 | 44.99 | |
| Baird | 27 Mar 2025 | 102.00 (127.78%) | 购买 | 67.39 |
| Cantor Fitzgerald | 27 Mar 2025 | 123.00 (174.68%) | 购买 | 67.39 |
| Laidlaw & Co. | 27 Mar 2025 | 105.00 (134.48%) | 购买 | 67.39 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合